Tech Company Financing Transactions
Hemosense Funding Round
Hemosense secured a funding round on 8/7/2003. Investors included MPM Capital and Vanguard Ventures.
Transaction Overview
Company Name
Announced On
8/7/2003
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The completion of this funding round is a testament to the strength of the HemoSense technology and markets we serve.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
651 River Oaks Parkway
San Jose, CA 95134
USA
San Jose, CA 95134
USA
Phone
Website
Email Address
Overview
HemoSense develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication. Warfarin is an oral anticoagulant, or blood thinning, drug given to patients to prevent potentially lethal blood clots.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Merselis
Chief Financial Officer
Gordon Sangster
Executive Vice President
Timothy Still
VP - Operations
William Dippel
Browse more venture capital transactions:
Prev: 8/7/2003: Scopus Network Technologies venture capital transaction
Next: 8/8/2003: LightSand Communications venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs